vs
Apellis Pharmaceuticals, Inc.(APLS)与INTERFACE INC(TILE)财务数据对比。点击上方公司名可切换其他公司
INTERFACE INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.7倍($349.4M vs $199.9M),INTERFACE INC净利率更高(7.0% vs -29.5%,领先36.5%),INTERFACE INC同比增速更快(4.3% vs -5.9%),INTERFACE INC自由现金流更多($28.6M vs $-14.3M),过去两年INTERFACE INC的营收复合增速更高(9.8% vs 7.7%)
Apellis Pharmaceuticals是一家临床阶段生物制药企业,专注于开发调节补体系统的靶向疗法,适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病,核心市场为美国及欧盟地区。
Interface Inc.总部位于美国佐治亚州亚特兰大,是全球知名的商用地板制造商,主营产品涵盖模块化地毯砖、 luxury vinyl tile(高端乙烯基地砖)以及Nora品牌橡胶地板,产品广泛应用于各类商业空间场景。
APLS vs TILE — 直观对比
营收规模更大
TILE
是对方的1.7倍
$199.9M
营收增速更快
TILE
高出10.2%
-5.9%
净利率更高
TILE
高出36.5%
-29.5%
自由现金流更多
TILE
多$42.9M
$-14.3M
两年增速更快
TILE
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $199.9M | $349.4M |
| 净利润 | $-59.0M | $24.4M |
| 毛利率 | — | 38.6% |
| 营业利润率 | -25.6% | 10.1% |
| 净利率 | -29.5% | 7.0% |
| 营收同比 | -5.9% | 4.3% |
| 净利润同比 | -62.2% | 12.1% |
| 每股收益(稀释后) | $-0.40 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APLS
TILE
| Q4 25 | $199.9M | $349.4M | ||
| Q3 25 | $458.6M | $364.5M | ||
| Q2 25 | $178.5M | $375.5M | ||
| Q1 25 | $166.8M | $297.4M | ||
| Q4 24 | $212.5M | $335.0M | ||
| Q3 24 | $196.8M | $344.3M | ||
| Q2 24 | $199.7M | $346.6M | ||
| Q1 24 | $172.3M | $289.7M |
净利润
APLS
TILE
| Q4 25 | $-59.0M | $24.4M | ||
| Q3 25 | $215.7M | $46.1M | ||
| Q2 25 | $-42.2M | $32.6M | ||
| Q1 25 | $-92.2M | $13.0M | ||
| Q4 24 | $-36.4M | $21.8M | ||
| Q3 24 | $-57.4M | $28.4M | ||
| Q2 24 | $-37.7M | $22.6M | ||
| Q1 24 | $-66.4M | $14.2M |
毛利率
APLS
TILE
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 38.1% |
营业利润率
APLS
TILE
| Q4 25 | -25.6% | 10.1% | ||
| Q3 25 | 48.7% | 14.6% | ||
| Q2 25 | -18.6% | 13.9% | ||
| Q1 25 | -50.0% | 7.8% | ||
| Q4 24 | -12.3% | 8.8% | ||
| Q3 24 | -24.0% | 12.3% | ||
| Q2 24 | -14.7% | 11.0% | ||
| Q1 24 | -36.0% | 8.4% |
净利率
APLS
TILE
| Q4 25 | -29.5% | 7.0% | ||
| Q3 25 | 47.0% | 12.7% | ||
| Q2 25 | -23.6% | 8.7% | ||
| Q1 25 | -55.3% | 4.4% | ||
| Q4 24 | -17.1% | 6.5% | ||
| Q3 24 | -29.2% | 8.3% | ||
| Q2 24 | -18.9% | 6.5% | ||
| Q1 24 | -38.5% | 4.9% |
每股收益(稀释后)
APLS
TILE
| Q4 25 | $-0.40 | $0.41 | ||
| Q3 25 | $1.67 | $0.78 | ||
| Q2 25 | $-0.33 | $0.55 | ||
| Q1 25 | $-0.74 | $0.22 | ||
| Q4 24 | $-0.30 | $0.38 | ||
| Q3 24 | $-0.46 | $0.48 | ||
| Q2 24 | $-0.30 | $0.38 | ||
| Q1 24 | $-0.54 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $71.3M |
| 总债务越低越好 | — | $181.6M |
| 股东权益账面价值 | $370.1M | $640.7M |
| 总资产 | $1.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势,按日历期对齐
现金及短期投资
APLS
TILE
| Q4 25 | $466.2M | $71.3M | ||
| Q3 25 | $479.2M | $187.4M | ||
| Q2 25 | $370.0M | $121.7M | ||
| Q1 25 | $358.4M | $97.8M | ||
| Q4 24 | $411.3M | $99.2M | ||
| Q3 24 | $396.9M | $115.6M | ||
| Q2 24 | $360.1M | $94.2M | ||
| Q1 24 | $325.9M | $89.8M |
总债务
APLS
TILE
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $307.8M | ||
| Q2 25 | — | $304.4M | ||
| Q1 25 | — | $302.9M | ||
| Q4 24 | — | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | $93.1M | $391.8M |
股东权益
APLS
TILE
| Q4 25 | $370.1M | $640.7M | ||
| Q3 25 | $401.2M | $621.0M | ||
| Q2 25 | $156.3M | $575.0M | ||
| Q1 25 | $164.2M | $513.1M | ||
| Q4 24 | $228.5M | $489.1M | ||
| Q3 24 | $237.1M | $501.6M | ||
| Q2 24 | $264.3M | $451.2M | ||
| Q1 24 | $266.7M | $428.5M |
总资产
APLS
TILE
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $821.4M | $1.3B | ||
| Q1 25 | $807.3M | $1.2B | ||
| Q4 24 | $885.1M | $1.2B | ||
| Q3 24 | $901.9M | $1.2B | ||
| Q2 24 | $904.5M | $1.2B | ||
| Q1 24 | $831.9M | $1.2B |
负债/权益比
APLS
TILE
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | 0.35× | 0.91× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $49.3M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $28.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 8.2% |
| 资本支出强度资本支出/营收 | 0.1% | 5.9% |
| 现金转化率经营现金流/净利润 | — | 2.02× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $121.7M |
8季度趋势,按日历期对齐
经营现金流
APLS
TILE
| Q4 25 | $-14.2M | $49.3M | ||
| Q3 25 | $108.5M | $76.7M | ||
| Q2 25 | $4.4M | $30.1M | ||
| Q1 25 | $-53.4M | $11.7M | ||
| Q4 24 | $19.4M | $38.0M | ||
| Q3 24 | $34.1M | $76.2M | ||
| Q2 24 | $-8.3M | $21.5M | ||
| Q1 24 | $-133.0M | $12.6M |
自由现金流
APLS
TILE
| Q4 25 | $-14.3M | $28.6M | ||
| Q3 25 | $108.3M | $66.1M | ||
| Q2 25 | $4.4M | $22.8M | ||
| Q1 25 | $-53.4M | $4.3M | ||
| Q4 24 | $19.3M | $24.4M | ||
| Q3 24 | — | $69.7M | ||
| Q2 24 | $-8.4M | $12.0M | ||
| Q1 24 | $-133.3M | $8.6M |
自由现金流率
APLS
TILE
| Q4 25 | -7.1% | 8.2% | ||
| Q3 25 | 23.6% | 18.1% | ||
| Q2 25 | 2.5% | 6.1% | ||
| Q1 25 | -32.0% | 1.4% | ||
| Q4 24 | 9.1% | 7.3% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | -4.2% | 3.5% | ||
| Q1 24 | -77.3% | 3.0% |
资本支出强度
APLS
TILE
| Q4 25 | 0.1% | 5.9% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 2.0% | ||
| Q1 25 | 0.0% | 2.5% | ||
| Q4 24 | 0.0% | 4.1% | ||
| Q3 24 | 0.0% | 1.9% | ||
| Q2 24 | 0.0% | 2.8% | ||
| Q1 24 | 0.2% | 1.4% |
现金转化率
APLS
TILE
| Q4 25 | — | 2.02× | ||
| Q3 25 | 0.50× | 1.66× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | — | 0.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |